MétaCan
Menu
Back to cohort
Record W4415987135 · doi:10.1177/23814683251386887

Treatment Preferences among Patients with Hormone-Sensitive Prostate Cancer in France, Spain, China, South Korea, and Japan: A Discrete-Choice Experiment

2025· article· en· W4415987135 on OpenAlexaff
Juan Marcos González, Arijit Ganguli, Amee Morgans, Bertrand Tombal, Sebastién J. Hotte, Hiroyoshi Suzuki, Daniel Ng, Charles D. Scales, Matthew J. Wallace, Jui‐Chen Yang, Daniel J. George

Bibliographic record

VenueMDM Policy & Practice · 2025
Typearticle
Languageen
FieldEconomics, Econometrics and Finance
TopicEconomic and Environmental Valuation
Canadian institutionsMcMaster UniversityJuravinski Cancer Centre
FundersAstellas PharmaPfizer
KeywordsProstate cancerHealth careMEDLINEDiseaseCancerClinical trial

Abstract

fetched live from OpenAlex

Background. Treatment preferences of patients with high-risk localized prostate cancer (HRLPC) and metastatic hormone-sensitive prostate cancer (mHSPC) are expected to be influenced by cultural and institutional differences across countries. We aimed to evaluate this expectation by quantifying the importance of treatment outcomes for patients with HRLPC and mHSPC. Methods. A discrete-choice experiment survey included adults (≥18 y of age) diagnosed with HRLPC or mHSPC from 5 countries—France, Spain, China, South Korea, and Japan—with or without previous experience of androgen-deprivation therapy. A latent-class random-parameters logit model was used to evaluate the importance patients assigned to treatment attributes and the consistency in treatment preferences across the 5 countries. Results. In total, 468 patients completed the survey. Respondents with shared treatment preferences from all 5 countries had a chance of being in pooled class 1 (44.5%) or pooled class 2 (37.9%). The main factors of concern were skin rash, fatigue, and use of steroids for pooled class 1 and chemotherapy-associated problems for pooled class 2. Our analysis could not explain class assignments based on clinically relevant characteristics of patients, which were used as covariates. Conclusion. Despite cultural and institutional differences across the 5 countries, our model identified significant consistency in treatment preferences among patients with prostate cancer. Given the attribute levels in our study, efficacy was the most significant driver of patient preference. We also found that using 2 sets of preferences was sufficient to reasonably characterize the perspectives of about 80% of surveyed patients. That these 2 patient classes differed in terms of treatment concerns but not in clinical factors highlights the need for promoting communication between patients and clinicians about treatment choices. Highlights Our study demonstrates that discrete-choice experiments (DCEs) are valuable for capturing health-related preferences among patients with prostate cancer. Contextual factors, such as efficacy and the country-specific health care system in which choices are presented, influence the ability to pool DCE data across countries. DCEs have the potential to enhance patient-centered care, shaping the future of evidence-based health care decision making.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.010
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score0.051

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0100.012
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0000.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.254
Teacher spread0.232 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueMDM Policy & PracticeSame topicEconomic and Environmental ValuationFrench-language works237,207